The U.S. Food and Drug Administration on May 17 authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, making everyone in the United States over the age of 5 eligible for a third shot.
FDA authorizes COVID-19 boosters for kids 5-11 as cases creep up
Antidepressants, BNT162b2 (Pfizer and BioNTech), Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 cases, COVID-19 Deaths, COVID-19 Vaccines, Death Tolls, Fluvoxamine, Generics, Health Outcomes, Healthcare Economics Outcomes Resesarch, Pandemics, Patient Deaths, Pfizer, SARS-CoV-2 virus, TherapeuticsOn May 17, the U.S. FDA authorized a booster of Pfizer’s vaccine for kids ages 5 to 11 years. The action comes as major cities are announcing a rise in cases. Additionally, COVID-19 would have claimed over 110,000 more lives in 2021 if not for the Pfizer-BioNTech vaccine, according to a Pfizer-sponsored report on the first year of the U.S. vaccination program.
AstraZeneca boosts COVID portfolio with RQ Bio deal
Acquisitions, AstraZeneca, Biotech, Business, Coronavirus Vaccines, COVID-19 Antibodies, COVID-19 shots, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 Vaccines, Evusheld (AstraZeneca), Evusheld (tixagevimab and cilgavimab; AstraZeneca), Licensing, R&D, Therapeutics, Vaxzevria (previously COVID-19 Vaccine AstraZeneca)AstraZeneca moved to bolster the company’s COVID-19 portfolio of antibodies on May 17 with a $157 million licensing deal for experimental therapies developed by newly launched biotech RQ Bio.
U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech’s COVID-19 vaccine for children aged 5 to 11 as soon as May 17, the New York Times reported on May 16, citing people familiar with the matter.
Leader Kim Jong Un ordered North Korea’s military to stabilize distribution of COVID-19 medicine in the capital, Pyongyang, in the battle against the country’s first confirmed outbreak of the disease, state media said.
Explainer: How North Korea’s COVID-19 outbreak could ignite a major health crisis
Coronavirus, Coronavirus Diagnostic Tests, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVAX Facility, COVID-19 Crisis, COVID-19 Deaths, COVID-19 Molecular Diagnostic Tests, COVID-19 self-testing kit, COVID-19 shots, COVID-19 Testing, Covid-19 Testing Guidance, COVID-19 Therapeutic, COVID-19 vaccination rates, COVID-19 Vaccinations, COVID-19 Vaccines, Diagnostic Tests, North Korea, Outbreaks, Pandemics, Politics, South Korea, Vaccinations, Vaccines, World Health OrganizationNorth Korea’s admission that it is battling an “explosive” COVID-19 outbreak raised concerns that the virus could devastate a country with an under-resourced health system, limited testing capabilities, and no vaccine program.
North Korea reports first COVID-19 death as fever spreads ‘explosively’
Coronavirus, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 Deaths, COVID-19 Self Test, COVID-19 Testing, COVID-19 Vaccines, North Korea, Outbreaks, Pandemics, Politics, Pyongyang, South Korea, Therapeutics, VaccinesAt least one person confirmed to have COVID-19 has died in North Korea and hundreds of thousands have shown fever symptoms, state media said on May 13, offering hints at the potentially dire scale of the country’s first confirmed outbreak of the pandemic.
The White House is preparing for a scenario in which Congress fails to approve President Joe Biden’s request for additional COVID funds by reviewing old contracts to see if there is any money it can “claw back,” the president’s top COVID adviser said on May 12.
Half of the COVID-19 patients discharged from a Chinese hospital in early 2020 still have at least one symptom two years later, a new study shows. Additionally, new findings suggest patterns of inflammatory proteins in the blood of people with long COVID may someday help guide individualized treatment.
U.S. will share COVID-19 vaccine technology, Biden tells global summit
Antivirals, BNT162b2 (Pfizer and BioNTech), Congress, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 Vaccines, Janssen COVID-19 Vaccine (J&J), Joe Biden, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemic Preparedness, Pandemics, Summits, Therapeutics, U.S. government, United States, Vaxzevria (previously COVID-19 Vaccine AstraZeneca), WHO, World Bank, World Health OrganizationThe United States will share technologies used to make COVID-19 vaccines through the World Health Organization and is working to expand rapid testing and antiviral treatments for hard-to-reach populations, President Joe Biden said on May 12.